Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 1, 2009, Pages 62-65

  Ozdemir, Ercan ^a   Cetinkaya, Sevil ^a   Ersan, Serpil ^a   Kucukosman, Seda ^a   Ersan, E Erdal ^b  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b Sivas Devlet Hastanesi   (Turkey)

Author keywords

Antioxidants; Free radicals; Malondialdehyde; Obsessive compulsive disorder; Selenium

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SELENIUM; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OBSESSIVE COMPULSIVE DISORDER; OXIDATIVE STRESS; STATISTICAL SIGNIFICANCE;

ADULT; ANTIOXIDANTS; FEMALE; FREE RADICALS; HUMANS; MALE; MALONDIALDEHYDE; OBSESSIVE-COMPULSIVE DISORDER; OXIDATIVE STRESS; SELENIUM;

EID: 58149347324     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.10.004     Document Type: Article

References (45)

1. Aebi H. Catalase. In: Bergmeyer H.U. (Ed). Methods of enzymatic analysis (1974), Academic Press, New York 673-677
2. Akyol O., Herken H., Uz E., Fadi{dotless}lli{dotless}oglu E., Unal S., Sogut S., et al. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog Neuro-psychopharmacol Biol Psychiatry 226 (2002) 995-1005
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, text revised (DSM-IV-TR). 4th ed. (2000), American Psychiatric Press, Washington, DC
4. Bains J.S., and Shaw C.A. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev 25 (1997) 335-358
5. Bilici M., Efeb H., Koroglu M.A., Uydu H.A., Bekaroglu M., and Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 4 (2001) 43-51
6. Burk R.F. Selenium (Se) and antioxidant mechanisms. Free Radic Res 40 (2006) S50
7. Burk R.F., and Lane J.M. Modification of chemical toxicity by selenium deficiency. Fundam Appl Toxicol 3 (1983) 218-221
8. Castano A., Cano J., and Machado A. Low selenium diet affects monoamine turnover differentially in substantia nigra and striatum. J Neurochem 61 (1993) 1302-1307
9. Cheeseman K.H., and Slater T.F. An introduction to free radical biochemistry. Br Med Bull 49 (1993) 481-493
10. Dubinina E.E., and Prustygina A.V. Free radical processes in aging, neurodegenerative diseases and other pathological states. Biomed Klim 53 4 (2007) 351-372
11. Ersan S., Baki{dotless}r S., Erdal Ersan E., and Dogan O. Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 30 (2006) 1039-1042
12. Farber L.J., Kyle E.M., and Coleman B.J. Biology of disease, mechanism of cell injury by activated oxygen species. Lab Invest 62 (1990) 670-679
13. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., Heninger G.R., and Charney D.S. The Yale-Brown Obsessive Compulsive Scale I. Development, use, and reliability. Arch Gen Psychiatry 46 11 (1989) 1006-1011
14. Graham D.G. Oxidative pathway for catecholoamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14 (1978) 633-643
15. Graham D.G. On the origin and significance of neuromelanin. Arch Pathol Lab Med 103 (1979) 359-362
16. Gutteridge J.M.C. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41 (1995) 1819-1828
17. Halliwell B. Oxidants and the central nervous system: some fundemental questions. Acta Neurol Scand 126 (1989) 23-33
18. Halliwell B., and Gutteridge J.M.C. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 246 (1986) 501-514
19. Hazneci E., Karabulut A.B., Ozturk C., Batcioglu K., Dogan G., Karaca S., et al. Comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients. Int J Dermatol 44 (2005) 636-640
20. Hill K.E., Zhou J., McMahan W.J., Motley A.K., and Burk R.F. Neurological dysfunction occurs in mice with targeted deletion of selenoprotein P gene. J Nutr 34 (2004) 157-161
21. Hirsch E.C. Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease. Ann Neurol 32 (1992) 88-93
22. Jain S.K. Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochim Biophys Acta 937 (1988) 205-210
23. Jesberger J.A. Oxygen free radicals and brain function. Int J Neurosci 57 (1991) 1-17
24. Karaca S., Kulac M., Uz E., Mollaoglu H., and Yi{dotless}lmaz R. Erythrocyte oxidant/antioxidant status in essential hyperhidrosis. Mol Cell Biochem 290 (2006) 131-135
25. Kryukov G.V., Castellano S., Novoselov S.V., Lobanov A.V., Zehtab O., Guigo R., et al. Characterization of mammalian selenoproteomes. Science 300 (2003) 1439-1443
26. Kuloglu M., Atmaca M., Tezcan E., Gecici O., Tunckol H., and Ustundag B. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology 46 (2002) 27-32
27. Lambertsen C.J. Transport of oxygen, carbon dioxide, and inert gases by the blood. In: Mouncastle V.B. (Ed). Medical physiology 2 (1980), CV Mosby Co, St Louis, MO 1722
28. Li Y., Severn A., Rogers M.V., Palmer R.M., Moncada S., and Liew F.Y. Catalase inhibits nitric oxide synthesis and the killing of intracellular Leishmania major in murine macrophages. Eur J Immunol 22 (1992) 441-446
29. Mahadik S.P., and Mukharjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr Res 19 (1996) 1-17
30. Mahadik S.P., Evans D., and Lal H. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 5 (2001) 463-493
31. McCord J.M. Oxygen derived radicals and reperfusion injury. Ann Intern Med 107 (1987) 526-545
32. Miller D.M., Buettner G.R., and Aust S.D. Transition metals as catalysts of autoxidation reactions. Free Radic Biol Med 8 (1990) 95-108
33. Murphy T.K., Sajid M.W., and Goodman W.K. Immunology of obsessive-compulsive disorder. Psychiatr Clin North Am 29 (2006) 445-469
34. Ozgocmen S., Sogut S., Ardicoglu O., Fadillioglu E., Pekkutucu I., and Akyol O. Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24 (2004) 80-83
35. Paglia D.E., and Valentine W.N. Studies on quantitative and qualitative characterization of erythrocyte gluthathione peroxidase. J Lab Clin Med 70 (1967) 158-168
36. Rayman M.P. The importance of selenium to human health. Lancet 356 (2000) 233-241
37. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., and Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 179 (1973) 588-590
38. Selek S., Herken H., Bulut M., Ceylan M.F., Clik H., Savas H.A., et al. Oxidative imbalance in obsessive-compulsive disorder patients: a total evaluation of oxidant-antioxidant status. Prog Neuro-Psychopharmacol Biol Psychiatry 32 (2008) 487-491
39. Sian J., Dexter D.T., Less A.J., Daniel S., Agid Y., Javoy-Agid F., et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36 (1994) 348-355
40. Sogut S., Zoroglu S.S., Ozyurt H., Yilmaz H.R., Ozugurlu F., Sivasli E., et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 331 (2003) 111-117
41. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 34 (1988) 497-500
42. Tezcan E., Atmaca M., Kuloglu M., and Ustundag B. Free radicals in patients with post-traumatic stress disorder. Eur Arch Psychiatry Clin Neurosci 253 (2003) 86-91
43. Weber G.F. The pathophysiology of reactive oxygen intermediates in the central nervous system. Med Hypotheses 43 (1994) 223-230
44. Welz B., Melcher M., and Schlemmer G. Bestimmung von Selen im menschlichen Blutserum. Anal Chem 316 (1983) 271-276
45. Yang J.G., Hill K.E., and Burk R.F. Dietary selenium intake controls rat plasma selenoprotein P concentration. J Nutr 119 (1989) 1010-1012